Chelation Therapy "Notification"
Under "When Covered" section: added extreme conditions of metal toxicity; treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) and due to nontransfusion-dependent thalassemia (NDTD); lead poisoning. Under "When Not Covered" section: added: "secondary prevention in patients with myocardial infarction" as investigational indication to 2nd bullet Atherosclerosis. Updated Regulatory status. Reference updated. Notification date 7/16/13 for effective date 10/1/13.